Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
Kyle L O’Donnell, Andrea Marzi Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USACorrespondence: Andrea Marzi Email marzia@niaid.nih.govAbstract: Ebola virus disease (EVD) remains...
Saved in:
Main Authors: | O'Donnell KL, Marzi A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/be1614737e824619a0a6e0158cf18527 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
by: J. Maximilian Fels, et al.
Published: (2019) -
Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection
by: Emily Speranza, et al.
Published: (2020) -
Modeling Ebola Virus Transmission Using Ferrets
by: Marc-Antoine de La Vega, et al.
Published: (2018) -
MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
by: E. I. Kazachinskaia, et al.
Published: (2014) - Monoclonal antibodies in immunodiagnosis and immunotherapy